However, widely explored biomarkers, like programmed cell death ligand 1(PD-L1) and tumor mutation burden (TMB), fail to predict responses to ICB in ccRCC [5–7]. The gene discussed is CD274; the disease is nonpapillary renal cell carcinoma.